Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Can a smartphone app beat the couch? new study tests online therapy for depression

NCT ID NCT02542891

Symptom relief Sponsor: Institut National de la Santé Et de la Recherche Médicale, France Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tested whether a blend of online and in-person therapy (called blended CBT) works as well as standard face-to-face therapy for adults with major depression. 105 participants were randomly assigned to either blended CBT or usual care. Researchers measured depression symptoms using a standard questionnaire to compare the two approaches.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
blended cognitive behavioral therapy (online and in-person sessions)
What this could lead to
If successful, this could show that online therapy is as effective as in-person therapy, making depression treatment more accessible.
What could go wrong
This is a completed trial with 105 participants, so results are limited in size and may not apply to everyone. Online therapy may not work for severe cases or those without reliable internet access.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

105 people

The number who actually took part.

Start date

Sep 2015

Finished

Sep 2018

Lead sponsor

A government agency

The lead sponsor is a government body.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Being 18 years of age or older * Meet DSM-IV diagnostic criteria for MDD confirmed by MINI International Neuropsychiatric Interview version 5.0 * Having a PHQ-9 score greater than 5 * Having access to a PC and Internet connection * Having ( or accepting to be loaned) a smartphone that is compatible with the mobile component of the intervention * Understanding of the French language spoken and written Exclusion Criteria: * Current high risk for suicide according to the MINI Interview section C * Serious psychiatric co-morbidity: substance dependence, bipolar affective disorder, psychotic illness, obsessive compulsive disorder, and suicide risks, as established at the MINI interview * Currently receiving psychological treatment for depression

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Depressive disorder are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

depressive disorder major depressive disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Depressive disorder

Contacts and locations

Locations

  • CHRU Lapeyronie

    Montpellier, 34295, France

  • CHU de Brest

    Brest, France

  • CHU de Clermont- Ferrnand

    Clermont-Ferrand, 63003, France

  • CHU de Grenoble

    Grenoble, France

  • CHU de Tours

    Tours, 37540, France

  • Centre Hospitalier Charles Perrens

    Bordeaux, 33076, France

  • Centre Hospitalier Le Vinatier-

    Bron, 69678, France

  • Hôpital A. Chenevier

    Créteil, 94010, France

  • Hôpital de la conception Pôle Psychiatrie Centre

    Marseille, 13005, France

  • Hôptial Fernand Widal

    Paris, 75010, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.